Partnered Content
Access key takeaways from a roundtable on the evolving landscape for rAAV-based gene therapies. Experts discussed approaches to clinical development, regulatory barriers, and the future outlook for AAV developers and lab services organizations.
Discover how eClinical technology is transforming clinical trials, increasing efficiencies, streamlining processes, and speeding time to market. Explore what lies ahead for eClinical tech and what it means for stakeholders in terms of innovation, collaboration, and overcoming tough challenges in clinical research.
Overcoming Immunogenicity And Safety Assessment Challenges For Biologics And Biosimilars In Oncology
Expert panelists discuss regulatory challenges, flexible approaches to assay selection, and applying scientific reasoning with guidelines to address immunogenicity and safety assessment challenges in oncology biologics and biosimilars.
In Sept 2024, a new CMDO, DMX Pharma, emerged on the global market. Explore the benefits of this merger, from production capacity to cross-selling capability, regulatory expertise and their ambitious future plans.
Learn more about how China’s biopharmas are going global by working with dependable and trustworthy companion diagnostics partners.
In this podcast, Janelle Hart, Managing Editor at Citeline, teams up with industry experts Mai Yee Mishir, Senior Director of Global Regulatory Affairs, and Sally-Ann McDowell, Senior Director of Clinical Development Strategy at Advanced Clinical, to discuss the vital role of HRQoL in clinical trials.